CINECA IRIS Institutional Research Information System

CALVO, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.245
EU - Europa 10.765
AS - Asia 4.872
SA - Sud America 295
OC - Oceania 200
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 17
Totale 29.449
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.872
IT - Italia 3.182
CN - Cina 2.293
IE - Irlanda 1.234
DE - Germania 1.072
SE - Svezia 836
FR - Francia 820
GB - Regno Unito 686
SG - Singapore 676
FI - Finlandia 631
KR - Corea 481
AT - Austria 477
JP - Giappone 422
UA - Ucraina 381
CA - Canada 330
ES - Italia 290
VN - Vietnam 265
NL - Olanda 261
IN - India 206
PL - Polonia 205
AU - Australia 180
BR - Brasile 179
BE - Belgio 146
TW - Taiwan 102
GR - Grecia 91
PT - Portogallo 85
HK - Hong Kong 84
CH - Svizzera 76
TR - Turchia 75
UZ - Uzbekistan 61
ID - Indonesia 58
IL - Israele 53
DK - Danimarca 52
CO - Colombia 43
AR - Argentina 37
HU - Ungheria 37
RO - Romania 37
RU - Federazione Russa 37
MX - Messico 36
CZ - Repubblica Ceca 28
CL - Cile 24
NO - Norvegia 23
IR - Iran 21
NZ - Nuova Zelanda 20
EU - Europa 17
PH - Filippine 17
BG - Bulgaria 16
SN - Senegal 13
TN - Tunisia 11
SI - Slovenia 10
TH - Thailandia 10
BY - Bielorussia 9
EG - Egitto 9
HR - Croazia 8
RS - Serbia 8
MY - Malesia 7
BA - Bosnia-Erzegovina 6
ZA - Sudafrica 6
CI - Costa d'Avorio 5
UY - Uruguay 5
EC - Ecuador 4
IQ - Iraq 4
IS - Islanda 4
KZ - Kazakistan 4
MU - Mauritius 4
NP - Nepal 4
PK - Pakistan 4
PS - Palestinian Territory 4
CY - Cipro 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MD - Moldavia 3
MK - Macedonia 3
SA - Arabia Saudita 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
LB - Libano 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
TL - Timor Orientale 2
AL - Albania 1
BF - Burkina Faso 1
CR - Costa Rica 1
GH - Ghana 1
HN - Honduras 1
IM - Isola di Man 1
KE - Kenya 1
LT - Lituania 1
MO - Macao, regione amministrativa speciale della Cina 1
MW - Malawi 1
QA - Qatar 1
SV - El Salvador 1
VE - Venezuela 1
Totale 29.449
Salva come PNG Salva come JPEG
Città #
Chandler 1.718
Beijing 1.240
Dublin 1.191
Houston 770
Ashburn 727
Torino 668
Fairfield 627
Singapore 496
Vienna 442
Ann Arbor 430
Villeurbanne 412
Jacksonville 387
Wilmington 361
Princeton 349
Redwood City 341
Medford 339
Woodbridge 331
Nyköping 299
Seattle 295
Cambridge 240
Turin 225
Milan 224
Dearborn 222
Fremont 194
Warsaw 181
Dong Ket 169
Pisa 145
Lappeenranta 141
Boston 139
Rome 115
Guangzhou 113
Toronto 102
Tokyo 101
New York 96
Boardman 91
Santa Clara 89
Chengdu 86
London 86
Nanjing 85
Paris 83
Brussels 69
Taipei 66
Shanghai 65
Hangzhou 60
Washington 58
Chicago 57
San Diego 54
Jakarta 50
Hefei 49
Ottawa 46
Norwalk 45
Sydney 43
Los Angeles 41
Helsinki 40
Utrecht 40
Berlin 39
Budapest 35
Nürnberg 34
San Francisco 34
Munich 31
Padova 31
Seoul 31
Wuhan 31
Athens 30
Detroit 29
Falls Church 29
Mountain View 28
Bologna 27
Shenyang 27
Hong Kong 26
Kunming 26
Lisbon 26
Oxford 26
Phoenix 26
Zhengzhou 26
Florence 25
Genoa 25
Hebei 24
Madrid 24
Silver Spring 24
Buenos Aires 23
Valencia 23
Atlanta 22
Istanbul 22
Palermo 22
São Paulo 22
Amsterdam 21
Cervignano Del Friuli 21
Changsha 21
Fuzhou 21
Melbourne 21
Philadelphia 21
Pittsburgh 21
Serra 21
Jinan 20
San Mateo 20
Barcelona 19
Brisbane 19
Stockholm 19
Verona 19
Totale 16.265
Salva come PNG Salva come JPEG
Nome #
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model 3.066
Specialist palliative care improves the quality of life in advanced neurodegenerative disorders: NE-PAL, a pilot randomised controlled study 1.450
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study 604
A20 in Multiple Sclerosis and Parkinson’s Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways? 507
C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson’s disease complicated by psychosis or dementia in a Sardinian population 387
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. 383
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy 320
The Italian multicenter experience with edaravone in amyotrophic lateral sclerosis 308
Acoustic reflex patterns in amyotrophic lateral sclerosis 292
Decreased Levels of Foldase and Chaperone Proteins Are Associated with an Early-Onset Amyotrophic Lateral Sclerosis 286
Influence of frontotemporal dementia in ALS patients and caregivers quality of life and depression 275
Validation of the revised classification of cognitive and behavioural impairment in ALS 248
The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease 231
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 230
Curable or treatable? The implications of different definitions of illness when treating patients affected by Amyotrophic Lateral Sclerosis 229
Validation of the Italian version of self-administered ALSFRS-R scale 227
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 212
Projected increase in amyotrophic lateral sclerosis from 2015 to 2040 211
Amyotrophic Lateral Sclerosis Incidence and Previous Prescriptions of Drugs for the Nervous System 210
Acute, Hemorrhagic, Necrotizing Pancreatitis Associated With Riluzole Treatment in a Patient With Amyotrophic Lateral Sclerosis 210
Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. 206
The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring 203
G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo 201
ATXN2 polyQ intermediate repeats are a modifier of ALS survival. 189
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. 188
18 F-FDG-PET correlates of cognitive impairment in ALS 185
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 183
SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis 173
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 168
Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor. 167
Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD 166
Factors predicting survival in ALS: a multicenter Italian study 165
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 163
C9ORF72 hexanucleotide repeat exerts toxicity in a stable, inducible motor neuronal cell model, which is rescued by partial depletion of Pten 153
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 151
Secular trends of amyotrophic lateral sclerosis: The Piemonte and Valle d’Aosta register 151
A longitudinal study on quality of life and depression in ALS patient-caregiver couples 150
NOX2 in the hSOD1G93A Transgenic Swine: a preliminary overview 149
The multistep hypothesis of ALS revisited: The role of genetic mutations 146
ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons 144
Diffusion Tensor and Voxel Based Morphometry study in patients with amyotrophic lateral sclerosis 142
La continuità assistenziale: miraggio o possibilità? 140
Erythropoietin in amyotrophic lateral sclerosis: A multicentre, randomised, double blind, placebo controlled, phase III study 139
Large Proportion of Amyotrophic Lateral Sclerosis Cases in Sardinia Due to a Single Founder Mutation of the TARDBP Gene 135
Does Recognition of Facial Expression of Primary and Social Emotions in ASL Patients Interfere with Social Competence? 134
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian consensus conference on pain in neurorehabilitation 134
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanisms 134
Spatial epidemiology of Amyotrophic Lateral Sclerosis in Piedmont and Aosta Valley, Italy: a population-based cluster analysis 131
A Strange Loop: Effects of emotional facial expressions impaired recognition in ALS Patients and in their Caregivers. 129
Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis 127
Can eye-tracking system communication improve quality of life and mood in ALS patients with locked-in syndrome 126
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 125
Influence of cigarette smoking on ALS outcome: A population-based study 124
A Distinct MR Imaging Phenotype in Amyotrophic Lateral Sclerosis: Correlation between T1 Magnetization Transfer Contrast Hyperintensity along the Corticospinal Tract and Diffusion Tensor Imaging Analysis. 124
Expression of NOX2 protein in neutrophils of patients with ALS 117
Increased risk of ALS for frontline workers 116
Persistent idiopathic hypoglossal nerve palsy: A motor neuron disease-mimic syndrome? 115
Increased cytoplasmic mislocalization of TAR DNA binding protein 43 (TDP-43) in circulating lymphomonocytes of ALS patients recapitulates the major dysfunction featuring motor neurons in the disease. 114
Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls 113
Endogenous Cognitive Tasks for Brain-Computer Interface: A Mini-Review and a New Proposal 110
Cognitive impairment across ALS clinical stages in a population-based cohort 109
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) 106
NADPH Oxidases (NOX) Enzymes Induced Oxidative Stress in CIDP Patients 105
Genetic counselling in ALS: facts, uncertainties and clinical suggestions 105
Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis 103
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 102
A 10-year epidemiological prospective study of ALS in Piemonte and Valle d'Aosta, italy 101
Are arterial hypertension and diabetes modifiers of ALS phenotype and outcome? A population-based study 100
Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis 100
HFE p.H63D polymorphism does not influence ALS phenotype and survival 99
Studio longitudinale sulla qualità di vita in pazienti affetti da SLA arruolati e non arruali in clinical trial 98
ALS patients and caregivers communication preferences and information seeking behaviour 96
Disfagia in Neurologia 96
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis 93
Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations 92
Extensive genetics of ALS: A population-based study in Italy 92
Monocytes of patients with Amyotrophic Lateral Sclerosis linked to gene mutations display altered TDP-43 subcellular distribution 92
Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities 91
Lithium carbonate does not prevent ALS: a case-report of four patients on long-term therapy for the treatment of bipolar disorder 90
NADPH oxidase (NOX2) activity is a modifier of survival in ALS 90
C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population 89
Does Recognition of Facial Expression of Primary and Social Emotions in ALS Patients Interfere with Social Competence? 89
NADPH oxidases (NOX) enzymes induced oxidative stress in CIDP patients 89
ALS clinical trials: Do enrolled patients accurately represent the ALS population? 89
Progranulin plasma levels in relation to the expected TDP-43 pathology. 87
Amyotrophic lateral sclerosis mimic syndrome due to a dorsal spinal cord neurofibroma 87
Lower serum lipid levels are related to respiratory impairment in patient with ALS 86
NADPH oxidase (NOX2) activity is a modifier of survival in ALS. 86
A novel p.E121G heterozygous missense mutation of SOD1 in an apparently sporadic ALS case with a 14-year course. 86
A familial ALS case carrying a novel p.G147C SOD1 heterozygous missense mutation with non-executive cognitive impairment. 85
The transcription factor Nurr1 is up-regulated in Amyotrophic Lateral Sclerosis patients and SOD1-G93A mice 85
Progranulin plasma levels in patients with and without TDP-43 pathology. 85
Segni e sintomi inusuali o rari in Neurologia 85
The diagnosis of FTD-ALS: a longitudinal study in a specialized dementia unit 84
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis 84
Early weight loss in amyotrophic lateral sclerosis: Outcome relevance and clinical correlates in a population-based cohort 84
Common polymorphisms of chemokine (C-X3-C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population-based study 84
Role of NOX2 enzyme activity in neuroinflammation: preliminary results in Amyotrophic Lateral Sclerosis and Parkinson’s disease 83
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 82
ALS Clinical Trials: Do the Enrolled Patients Represent the ALS Population? 81
Totale 19.486
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.933
article - articoli 0
book - libri 0
conference - conferenze 17.149
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.082
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.474 0 0 182 370 237 662 434 278 383 454 249 225
2020/20213.471 305 233 221 191 280 251 273 255 480 325 192 465
2021/20224.039 181 148 200 342 248 258 238 241 207 365 835 776
2022/20236.007 662 485 201 514 534 1.350 475 377 639 234 316 220
2023/20244.037 393 502 267 289 244 332 252 532 72 387 330 437
2024/20251.072 223 625 224 0 0 0 0 0 0 0 0 0
Totale 30.376